Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Portman

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Sexual Medicine|August 27, 2014
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause SocietyDavid J Portman, Margery L S Gass,
Menopause (New York, N.Y.)|August 28, 2014
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause SocietyDavid J Portman, Margery L S Gass,
Menopause (New York, N.Y.)|January 31, 2013
Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophyDavid J Portman, Gloria A Bachmann, James A Simon, et al.
Menopause (New York, N.Y.)|February 25, 2016
To the EditorDavid J Portman, David F Archer, Céline Martel, et al.
American Journal of Obstetrics and Gynecology|February 20, 2003
A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol aloneDavid J Portman, James P Symons, Walter Wilborn, et al.
Contraception|April 4, 2009
Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptiveAndrew M Kaunitz, David J Portman, Howard Hait, et al.
The Journal of Sexual Medicine|June 7, 2017
Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA StudyDavid J Portman, Louise Brown, James Yuan, et al.
Expert Review of Endocrinology & Metabolism|September 19, 2019
Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopauseDavid F Archer, James A Simon, David J Portman, et al.
Menopause (New York, N.Y.)|February 21, 2014
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopauseDavid J Portman, Andrew M Kaunitz, Kazem Kazempour, et al.
Contraception|March 1, 2014
Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptiveDavid J Portman, Andrew M Kaunitz, Brandon Howard, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Sexual Medicine|August 27, 2014
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause SocietyDavid J Portman, Margery L S Gass,
Menopause (New York, N.Y.)|August 28, 2014
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause SocietyDavid J Portman, Margery L S Gass,
Menopause (New York, N.Y.)|January 31, 2013
Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophyDavid J Portman, Gloria A Bachmann, James A Simon, et al.
Menopause (New York, N.Y.)|February 25, 2016
To the EditorDavid J Portman, David F Archer, Céline Martel, et al.
American Journal of Obstetrics and Gynecology|February 20, 2003
A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol aloneDavid J Portman, James P Symons, Walter Wilborn, et al.
Contraception|April 4, 2009
Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptiveAndrew M Kaunitz, David J Portman, Howard Hait, et al.
The Journal of Sexual Medicine|June 7, 2017
Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA StudyDavid J Portman, Louise Brown, James Yuan, et al.
Expert Review of Endocrinology & Metabolism|September 19, 2019
Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopauseDavid F Archer, James A Simon, David J Portman, et al.
Menopause (New York, N.Y.)|February 21, 2014
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopauseDavid J Portman, Andrew M Kaunitz, Kazem Kazempour, et al.
Contraception|March 1, 2014
Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptiveDavid J Portman, Andrew M Kaunitz, Brandon Howard, et al.
Pageof 3